Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-52.82	19.73	41.83
Graham Fair Price	41.43	1.13	0.80
PEG	-58.64	-0.65	1.57
Price/Book	-8.70	0.08	0.08
Price/Cash Flow	23.34	4.76	3.86
Prices/Earnings	54.35	-64.87	-142.12
Price/Sales	-54.35	0.89	1.95
Price/FCF	23.34	4.76	3.86
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.56	0.56
Operating Margin	0.00	0.45	0.45
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-100.00
ROIC	< 0.005	< 0.005	116.15
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.02	-77.32
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	< 0.005	1.00	10394.92
EPS QOQ	0.91	-1.00	10.36
FCF QOQ	2.21	-0.26	-88.23
Revenue QOQ	-0.24	1.00	314.50
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	791.97	395.98	-50.00
Days Sales Outstanding (DSO)	3.40	4.10	20.69
Inventory Turnover	0.11	0.23	100.00
Debt/Capitalization	0.49	0.49	0.21
Quick Ratio	0.90	0.91	0.93
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	13.97	13.97	< 0.005
Cash	3.36	3.36	< 0.005
Capex	< 0.005	< 0.005	-100.01
Free Cash Flow	0.30	0.22	-25.97
Revenue	0.59	1.18	100.01
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.69	1.69	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	37.54	17.88	-52.37
Naive Interpretation	Member

06 - Financial Health · Weak

Rating